Skip to content
★ Sign in to follow
SV

S Vallance

Chairman
GlaxoSmithKline plc
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€489k

Latest filing published 18 Dec 2017 for GlaxoSmithKline plc, €489k.

Filing timeline

BuySale
S Vallance

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

S Vallance: trading record in brief

One trade, one date: on 18 December 2017, S Vallance disclosed an open-market sale of €489k in GlaxoSmithKline plc. No broader history exists yet. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to S Vallance

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▼
    PCA of Dr P J T Vallance (President, R&D)ExecutivesGlaxoSmithKline plc
    431,666 GBP27FCA-NSM
    32,974 shares@ £13.0911100.0% of flowLondon Stock Exchange, Main Market ( XLON)ISIN GB0009252882FCA-NSM:LSE20171218162115_13469766_20200330131510225_14405-1

1 of 1 declaration